Related Experiment Video
Updated: Dec 19, 2025

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
Seronegative occult hepatitis C infection among hemodialysis patients: A prevalence study
Shahab Mahmoudvand1,2, Somayeh Shokri2, Azarakhsh Azaran1,2
1Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Insights
Occult hepatitis C virus (HCV) infection (OCI) affects 6.3% of hemodialysis patients, detectable in PBMCs despite negative antibodies. Early detection of OCI in hemodialysis patients is crucial for managing complications.
Area of Science:
- Virology
- Infectious Diseases
- Nephrology
Background:
- Hepatitis C virus (HCV) infection poses risks to hemodialysis (HD) patients.
- Occult HCV infection (OCI), lacking detectable antibodies, presents diagnostic challenges.
Purpose of the Study:
- To determine the prevalence of OCI in HD patients.
- To evaluate diagnostic methods for OCI in this population.
Main Methods:
- Blood samples from 79 HD patients were analyzed.
- Sera tested for anti-HCV antibodies.
- HCV RNA detection in sera and peripheral blood mononuclear cells (PBMCs) using nested RT-PCR.
Main Results:
- Anti-HCV antibodies detected in 5.1% of patients.
- HCV RNA found in PBMCs of 6.3% of patients, indicating OCI.
- HCV genotype 3a was identified in all OCI cases.
- No significant gender-based difference in OCI frequency.
Conclusions:
- A 6.3% prevalence of OCI was found in HD patients.
- Sensitive methods detecting HCV RNA in PBMCs are essential for diagnosing OCI in HD patients.
- Implementing sensitive diagnostics for OCI is recommended for all HD patients due to potential complications.
Abstract:
The aim of this study was to investigate the prevalence of occult hepatitis C virus (HCV) infection (OCI) among HD patients. Blood samples were taken from 79 HD patients and their sera were evaluated for the presence of anti-HCV. Both the sera and peripheral blood mononuclear cells (PBMCs) were then checked for HCV RNA by nested reverse transcriptase-polymerase chain reaction. Anti-HCV was positive among 4/79 (5.1%) of the patients. From 75 patients who were negative for anti-HCV, 71 (94.7%) patients were also negative for HCV RNA in sera samples but five of them were positive for HCV RNA in PBMCs. Totally, out of 79 patients, HCV RNA was detected in PBMCs of five (6.3%) patients, indicating that these patients had OCI. No significant difference was observed between the frequency of OCI and gender (P-value = .6). HCV genotype in all five cases of OCI was genotype 3a. Our study showed prevalence rate of 6.3% OCI infection in HD patients. Regarding the serious complications and the clinical importance of OCI in HD patients, sensitive diagnostic methods for identifying HCV RNA in the PBMCs should be implemented for all HD patients.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Hemodialysis III: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Retrovirus Life Cycles

